Co-Founder Presents at FDA Conference on Oncofertility

Worth the Wait Co-Founder, Mike Scherer served as a patient advocate at the Food and Drug Administration’s (FDA) mini-symposium on oncofertility.

As a patient advocate speaker on this panel, featuring renowned reproductive physicians, he shared his experience with oncofertility as well as ways we can improve access to oncofertility care.

FDA Oncofertility Mini Symposium